SELLAS Life Sciences Group, Inc. — Director's Dealing 2013

Oct 15, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2013-10-11

Reporting Person: SCHWARTZ MARK W. (EVP, Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-10-11	Common Stock	A	7349	—	Acquired	504009	Direct

Footnotes

F1: The shares acquired were issued for the account of the reporting person at a value of $2.06 per share in payment of contingent value rights held by the reporting person.